High Dose of Phytoestrogens Can Reverse the Antiestrogenic Effects of Clomiphene Citrate on the Endometrium in Patients Undergoing Intrauterine Insemination: A Randomized Trial
Restricted accessResearch articleFirst published online July, 2004
High Dose of Phytoestrogens Can Reverse the Antiestrogenic Effects of Clomiphene Citrate on the Endometrium in Patients Undergoing Intrauterine Insemination: A Randomized Trial
Objective:To compare the effectiveness of clomiphene citrate (CC) alone or combined with phytoestrogens (PE) in ovulation induction in patients who had intrauterine insemination in a randomized, double-blind study.
Methods:A total of 134 women aged 25-35 years, who were infertile for at least 2 years and who had oligomenorrhea or amenorrhea associated with a positive menstrual response to the intramuscular progesterone-challenge test were enrolled. They were randomly treated with CC (100 mg daily for 5 days) and CC (100 mg daily for 5 days) in combination with PE (1500 mg daily for 10 days). We estimated the difference in uterine artery pulsatily index, number of preovulatory follicles, endometrial thickness, and pregnancy rate.
Results:Both treatments increased follicle-stimulating hormone, luteinizing hormone, and 17β-estradiol plasma concentrations, but the differences were not statistically significant. However, the differences in endometrial thickness of the two groups were statistically significant. No significant differences in the pulsatility index values and in the number of preovulatory follicles were noted.
Conclusion:A high dose of phytoestrogens can reverse the deleterious effects of clomiphene citrate on endometrial thickness and could contribute to higher pregnancy rates.
1. Greenblatt RB, Barfield WE, Jungck EC, Ray AW. Induction of ovulation with MRL-41. JAMA1961;178:101-106.
2.
2. Biljan MM, Mahutte NG, Tulandi T, Lin Tan S. Prospective randomized double-blind trial of the correlation between time of administration and antiestrogenic effects of clomiphene citrate on reproductive and organs. Fertil Steril1999;71:633-638.
3.
3. WHO Scientific Group Report. Consultation on the diagnosis and treatment of endocrine forms of female infertility. WHO Technical Report Series 514. Geneva: World Health Organization, 1976.
5. Shepard MK, Balmaceda JP, Leija CG. Relation of weight to successful induction of ovulation with clomiphene citrate. Fertil Steril1979;32:641-645.
6.
6. Lobo RA, Gysler M, March CM, Goebelsmann U, Mishell DR Jr. Clinical and laboratory predictors of clomiphene response. Fertil Steril1982;37:168-174.
7.
7. Speroff L, Glass RH, Kase NG. Induction of ovulation. In: Clinical gynecologic endocrinology and infertility. 5th ed.Baltimore: Williams & Wilkins, 1998:903-904.
8.
8. Hammond MG, Halme JK, Talbert LM. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Obstet Gynecol1983;62:196-202.
9.
9. Tiitinen AE, Laatikainen TJ, Seppala MT. Serum levels of insulin-like growth factor binding protein-1 and ovulatory responses to clomiphene citrate in women with polycystic ovarian disease. Fertil Steril1993;60:58-62.
10.
10. Wu CH, Winkel CA. The effect of therapy initiation day on clomiphene citrate therapy. Fertil Steril1982;37:441-444.
11.
11. Gysler M, March CM, Mishell DR, Bailey EJ. A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test. Fertil Steril1982;37:161-167.
12.
12. Drake TS, Tredway DR, Buchanan GC. Continued clinical experience with an increasing dosage regimen of clomiphene citrate administration. Fertil Steril1978;30:274-277.
13.
13. Massai MR, de Ziegler D, Lesobre V, Bergeron C, Frydman R, Bouchard P. Clomiphene citrate affects cervical in plasma hormonal levels induced by multiple follicular recruitment. Fertil Steril1993;59:1179-1186.
14.
14. Gelety TJ, Buyalos RP. The effect of clomiphene citrate and menopausal gonadotropins on cervical mucus in ovulatory cycles. Fertil Steril1993;60:471-476.
15.
15. Hsu CC, Kuo HC, Wang ST, Huang KE. Interference with uterine blood flow by clomiphene citrate in women with unexplained infertility. Obstet Gynecol1995;86:917-921.
16.
16. Xu X, Wang HJ, Murphy PA, Hendrich S. Neither background diet nor type of soy food affects short-term isoflavone bioavailability in women. J Nutr2000;130:798-801.
17.
17. Morito K, Aomori T, Hirose T, et al. Interaction of phytoestrogens with estrogen receptors alpha and beta (II). Biol Pharm Bull2002;25:48-52.
18.
18. Heikaus S, Winterhager E, Traub O, Grummer R. Responsiveness of endometrial genes Connexin26, Connexin43, C3 and clusterin to primary estrogen, selective estrogen receptor modulators, phyto- and xenoestrogens. J Mol Endocrinol2002;29:239-249.
19.
19. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol2002;3:364-373.
20.
20. Barnes S, Peterson TG, Coward L. Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J Cell Biochem1995;22(Suppl):181-187.
21.
21. Mueller SO, Kling M, Arifin Firzani P, et al. Activation of estrogen receptor alpha and ERbeta by 4-methylbenzylidene-camphor in human and rat cells: Comparison with phyto- and xenoestrogens. Toxicol Lett2003;142:89-101.
22.
22. Rickard DJ, Monroe DG, Ruesink TJ, Khosla S, Riggs BL, Spelsberg TC. Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors alpha and beta. J Cell Biochem2003;89:633-646.
23.
23. Lee Y, Jin Y, Lim W, et al. A ginsenoside-Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. J Steroid Biochem Mol Biol2003;84:463-468.
24.
24. Pearce V, Nawaz Z, Xiao W, Wiedenfeld D, Boyle N, Smith D. 4-Ethoxymethylphenol: A novel phytoestrogen that acts as an agonist for human estrogen receptors. J Steroid Biochem Mol Biol2003;84:431-439.
25.
25. Morito K, Hirose T, Kinjo J. Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull2001;24:351-356.
26.
26. Pike AC, Brzozowski AM, Hubbard RE, et al. Structure of the ligand-binding domain of estrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J1999;18:4608-4618.
27.
27. Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, Nilsson S. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol1998;54:105-112.
28.
28. Belcher SM, Zsarnovszky A. Estrogenic actions in the brain: Estrogen, phytoestrogens, and rapid intracellular signalling mechanisms. J Pharmacol Exp Ther2001;299:408-414.
29.
29. Diel P, Schulz T, Smolnikar K, Strunck E, Vollmer G, Michna H. Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: Estrogenicity profiles and uterotropic activity. J Steroid Biochem Mol Biol2000;73:1-10.
30.
30. Diel P, Smolnikar K, Schulz T, Laudenbach-Leschowski U, Michna H, Vollmer G. Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium. Hum Reprod2001;16:997-1006.
31.
31. Song TT, Hendrich S, Murphy PA. Estrogenic activity of glycitein, a soy isoflavone. J Agric Food Chem1999;47:1607-1610. Erratum in: J Agric Food Chem 2002;50:2470.
32.
32. Rickard DJ, Monroe DG, Ruesink TJ, Khosla S, Riggs BL, Spelsberg TC. Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors alpha and beta. J Cell Biochem2003;89:633-646.
33.
33. Lian Z, Niwa K, Tagami K, et al. Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice. Jpn J Cancer Res2001;92:726-734.
34.
34. Casanova M, You L, Gaido KW, Archibeque-Engle S, Janszen DB, Heck HA. Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors alpha and beta in vitro. Toxicol Sci1999;51:236-244.
35.
35. Zhang Y, Song TT, Cunnick JE, Murphy PA, Hendrich S. Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations. J Nutr1999;129:399-405.
36.
36. Schmitt E, Dekant W, Stopper H. Assaying the estrogenicity of phytoestrogens in cells of different estrogen sensitive tissues. Toxicol In Vitro2001;15:433-439.
37.
37. Jefferson WN, Padilla-Banks E, Clark G, Newbold RR. Assessing estrogenic activity of phytochemicals using transciptional activation and immature mouse uterotophic responses. J Chromatogr B Anal Technol Biomed Life Sci2002;777:179-189.
38.
38. Balk JL, Whiteside DA, Naus G, DeFerrari E, Roberts JM. A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium. J Soc Gynecol Investig2002;9:238-242.
39.
39. Penotti M, Babio E, Modena AB, Rinaldi M, Omodei U, Vigano P. Effect of soy-derived isoflavones on hot flushes, endometrial thickness and the pulsatility index of the uterine and cerebral arteries. Fertil Steril2003;79:1112-1117.
40.
40. Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: A multicenter, double-blind, randomized, placebo-controlled study. Menopause2000;7:422-426.
41.
41. Sammartino A, Di Carlo C, Mandato VD, Bifulco G, Di Stefano M, Nappi C. Effects of genistein on the endometrium: Ultrasonographic evaluation. Gynecol Endocrinol2003;17:45-49.
42.
42. Zaidi J, Jurgovic D, Campbell S, et al. Circadian variation in uterine artery blood flow during the follicular phase of menstrual cycle. Ultrasound Obstet Ginecol1995;5:406-411.
43.
43. World Health Organization. Laboratory manual for the examination of human semen-cervical mucus interaction. 2nd ed.Cambridge: The Press Syndicate of the University of Cambridge, 1987:3-10.
44.
44. Garcia J, Jones GS, Wentz AC. The use of clomiphene citrate. Fertil Steril1977;28:707-717.
45.
45. Goldfarb AF, Morales A, Rakoff AE, Protos P. Critical review of 160 clomiphene-related pregnancies. Obstet Gynecol1968;31:342-345.
46.
46. Goldstein D, Zuckerman H, Harpaz S, et al. Correlation between estradiol and progesterone in cycles with luteal phase deficiency. Fertil Steril1982;37:348-354.
47.
47. Hall EV, van Mastboom JL. Luteal phase insufficiency in patients treated with clomiphene. Am J Obstet Gynecol1969;15:165-171.
48.
48. Sterzik K, Dallenbach C, Schneider V, Sasse V, Dallenbach-Hellweg G. In vitro fertilization: The degree of endometrial insufficiency varies with the type of ovarian stimulation. Fertil Steril1988;50:457-462.
49.
49. Yeko TR, Nicosia SM, Maroulis GB, Bardawil WA, Dawood MY. Histology of midluteal corpus luteum and endometrium from clomiphene citrate-induced cycles. Fertil Steril1992;57:28-32.
50.
50. Fleischer AC, Pittaway DE, Beard LA, et al. Sonographic depiction of endometrial changes occurring with ovulation induction. J Ultrasound Med1984;3:341-346.
51.
51. Imoedemhe DA, Shaw RW, Kirkland A, Chan R. Ultrasound measurement of endometrial thickness on different ovarian stimulation regimens during in-vitro fertilization. Hum Reprod1987;2:545-547.
52.
52. Eden JA, Place J, Carter GD, Jones J, Alaghband-Zadeh J, Pawson ME. The effect of clomiphene citrate on follicular phase increase in endometrial thickness and uterine volume. Obstet Gynecol1989;73:187-190.
53.
53. Randall JM, Templeton A. Transvaginal sonographic assessment of follicular and endometrial growth in spontaneous and clomiphene citrate cycles. Fertil Steril1991;56:208-212.
54.
54. Zaidi J, Campbell S, Pittrof R, Tan SL, Endometrial thickness, morphology, vascular penetration and velocimetry in predicting implantation in an vitro fertilization program. Ultrasound Obstet Gynecol1995;6:191-198.
55.
55. Rogers PA, Polson D, Murphy CR, Hosie M, Susil B, Leoni M. Correlation of endometrial histology, morphometry, and ultrasound appearance after different stimulation protocols for in vitro fertilization. Fertil Steril1991;55:583-587.
56.
56. Gerli S, Gholami H, Manna A, Scotto Di Frega A, Vitiello C, Unfer V. Use of ethinyl estradiol to reverse the antiestrogenic effects of clomiphene citrate in patients undergoing intrauterine insemination: A comparative, randomized study. Fertil Steril2000;73:85-89.
57.
57. Bateman BG, Nunley WC Jr, Kolp LA. Exogenous estrogen therapy for treatment of clomiphene citrate-induced cervial mucus abnormalities: Is it effective?Fertil Steril1990;54:577-579.
58.
58. Dickey RP, Olar TT, Taylor SN, Curole DN, Rye PH. Sequential clomiphene citrate and human menopausal gonadotrophin for ovulation induction: Comparison to clomiphene citrate alone and human menopausal gonadotrophin alone. Hum Reprod1993;8:56-59.
59.
59. Harris HA, Katzenellenbogen JL, Katzenellenbogen BS. Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand. Endocrinology2002;143:4172-4177.
60.
60. Lecce G, Meduri G, Ancelin M, Bergeron C, Perrot-Applanat M. Presence of estrogen receptor beta in the human endometrium through the cycle: Expression in glandular, stromal, and vascular cells. J Clin Endocrinol Metab2001;86:1379-1386.
61.
61. Meduri G, Bausero P, Perrot-Applanat M. Expression of vascular endothelial growth factor receptors in the human endometrium: Modulation during the menstrual cycle. Biol Reprod2000;62:439-447.
62.
62. Kayisli UA, Aksu CA, Berkkanoglu M, Arici A. Estrogenicity of isoflavones on human endometrial stromal and glandular cells. J Clin Endocrinol Metab2002;87:5539-5544.
63.
63. Mylonas I, Jeschke U, Makovitzky J, et al. Immunohistochemical expression of steroid receptors and glycodelin A in isolated proliferative human endothelial glandular cells after stimulation with tamoxifen and phytoestrogens (genistein and daidzein). Anticancer Res2003;23:1119-1125.
64.
64. Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, Di Renzo GC. Endometrial effects of long term treatment with phytoestrogens: A randomized, double-blind, placebo-controlled study. Fertil Steril. 2004;82:1-4.
